Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private

BSE1729.05-14.8 (-0.85 %)

PREV CLOSE ( ) 1743.85

OPEN PRICE ( ) 1758.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 16516

TODAY'S LOW / HIGH ( )1723.00 1758.95

52 WK LOW / HIGH ( )861.5 2195.75

NSE1728.35-10.25 (-0.59 %)

PREV CLOSE( ) 1738.60

OPEN PRICE ( ) 1756.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1728.35 (120)

VOLUME 166537

TODAY'S LOW / HIGH( ) 1722.00 1756.70

52 WK LOW / HIGH ( )861 2194

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-03 1978

Management Info

Yiu Kwan Stanley Lau - Chairman Srinivas Sadu - Managing Director

Registered Office

Address Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal- Malkajgiri District,
Hyderabad,
Telangana-500043

Phone 040 30510999

Email gland@glandpharma.com / investor@glandpharma.com

Website www.glandpharma.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

10Apr Clarification sought from Gland Pharm
The Exchange has sought clarification from Gland Pharma Ltd on April 10,..

08Apr Gland Pharma gets USFDA’s approval for
Gland Pharma has received approval from the United States Food and Drug..

08Apr Gland Pharma shines on getting USFDA’s
Gland Pharma is currently trading at Rs. 1848.00, up by 92.85 points or..

21Feb Gland Pharma informs about earnings ca
Gland Pharma has informed that it enclosed the transcript of the Earning..

18Jan Gland Pharma informs about analyst meet
Gland Pharma has informed that the Earnings Call for Investors/Analysts..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	2768.05	7758.26
Gross Profit	3717.55	10484.02
Operating Profit	4128.8	12590.13
Net Sales	10978.61	36165.28

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE) 4025.35 (4.81%)	M.Cap ( in Cr)106860.39
Sanofi India (BSE) 8278.10 (1.76%)	M.Cap ( in Cr)19064.98
Abbott India (BSE) 25864.85 (0.54%)	M.Cap ( in Cr)54961.00
Astrazeneca Pharma I (BSE) 5415.40 (2.18%)	M.Cap ( in Cr)13538.50
Glaxosmithkline Phar (BSE) 2132.75 (3.26%)	M.Cap ( in Cr)36130.07

Shareholding Pattern

	PROMOTERS	57.86%
	MUTUAL FUNDS/UTI	23.01%
	NON-INSTITUTION	13.32%
	FI/BANKS/INSURANCE	1.21%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Nippon India Pharma...	4.40
SBI Healthcare Opp ...	4.22
Mirae Asset Healthc...	4.10
Aditya Birla SL Pha...	3.59
SBI Magnum Global F...	3.23
HDFC Pharma and Hea...	3.22
UTI Healthcare Fund...	2.92

Risk Disclosures on Derivatives

Smart Quotes

GLAND PHARMA LTD.